These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3931294)

  • 1. Turnover of tissue plasminogen activator in normal and hepatectomized rabbits.
    Nilsson S; Einarsson M; Ekvärn S; Häggroth L; Mattsson C
    Thromb Res; 1985 Aug; 39(4):511-21. PubMed ID: 3931294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of human tissue plasminogen activator (tPA) in rabbits.
    Beebe DP; Aronson DL
    Thromb Res; 1986 Sep; 43(6):663-74. PubMed ID: 3094193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits.
    Korninger C; Stassen JM; Collen D
    Thromb Haemost; 1981 Oct; 46(3):658-61. PubMed ID: 7198302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of tPA in rabbits: influence of carbohydrate moieties.
    Beebe DP; Aronson DL
    Thromb Res; 1988 Jul; 51(1):11-22. PubMed ID: 3137690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
    Einarsson M; Hggroth L; Mattsson C
    Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.
    Appasamy R; Tanabe M; Murase N; Zarnegar R; Venkataramanan R; Van Thiel DH; Michalopoulos GK
    Lab Invest; 1993 Mar; 68(3):270-6. PubMed ID: 8450646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition.
    Ganguly K; Murciano JC; Westrick R; Leferovich J; Cines DB; Muzykantov VR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):158-64. PubMed ID: 17215448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A faster-acting and more potent form of tissue plasminogen activator.
    Keyt BA; Paoni NF; Refino CJ; Berleau L; Nguyen H; Chow A; Lai J; Peña L; Pater C; Ogez J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3670-4. PubMed ID: 8170967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and regulation of tissue plasminogen activator activity in rat cumulus-oocyte complexes.
    Liu YX; NY T; Sarkar D; Loskutoff D; Hsueh AJ
    Endocrinology; 1986 Oct; 119(4):1578-87. PubMed ID: 3093195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.
    Runge MS; Bode C; Matsueda GR; Haber E
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7659-62. PubMed ID: 3118374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo.
    Mattsson C; Nilsson S; Häggroth L
    Thromb Res; 1983 Apr; 30(1):91-100. PubMed ID: 6683005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.
    Chandler WL; Levy WC; Stratton JR
    Circulation; 1995 Nov; 92(10):2984-94. PubMed ID: 7586269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels.
    Chandler WL; Alessi MC; Aillaud MF; Henderson P; Vague P; Juhan-Vague I
    Circulation; 1997 Aug; 96(3):761-8. PubMed ID: 9264480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.